The global Bone Cement & Glue Market in terms of revenue was estimated to be worth $1,644 million in 2023 and is poised to reach $2,248 million by 2028, growing at a CAGR of 6.5% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of this market is majorly driven by the Rising Demand for Minimally Invasive Surgeries with robotic assistance and Growing healthcare sector and Increasing Incidence of Orthopedic Conditions. However, Challenges associated with Variability of pathogen resistance may threat the growth of this market.

Some of the major players operating in this market are Stryker (US), Zimmer Biomet (US) , Smith+Nephew (UK), DePuy Synthes (a subsidiary of Johnson & Johnson - US) , Enovis  (US) , Artivion, Inc (US), Cardinal Health. (US), Medtronic (Ireland), Globus Medical (US), and Heraeus Holding (Germany).

Download a FREE Sample PDF of the Global Bone Cement & Glue Market Research Report at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131540876+&utm_source=Ganesh&utm_medium=P

Recession Impact on the Bone Cement & Glue Market

The impact of a global recession can vary across different regions and countries. Economic conditions, healthcare systems, and regulatory environments differ worldwide, and the severity and duration of the recession will also influence the extent of its impact on the bone cement & glue market globally. During a global recession, the bone cement & glue market could experience several potential impacts. Such as During a recession, healthcare budgets may be reduced as governments and individuals prioritize essential needs. This can lead to a decrease in demand for bone cement & glue as healthcare providers face financial constraints, Economic downturns often result in increased price sensitivity among healthcare providers and consumers. Manufacturers and suppliers of bone cement & glue may face pricing pressure as healthcare organizations seek more cost-effective alternatives or negotiate lower prices, in a recession, individuals may delay elective medical procedures due to financial constraints. This can impact the demand for bone cement & glue, particularly in orthopedic surgical procedures.

Based on Type, the Bone Glue market is segmented into Natural bone glue and Synthetic bone glue. The Natural bone glue segment is anticipated to have the highest shares during. The major factors contributing to the growth of this market are the potential advantages of natural bone glue include better biocompatibility, reduced risk of adverse reactions, and the ability to support tissue regeneration and healing. However, the development and commercialization of natural bone glue products have faced challenges such as standardization, and regulatory approvals.

Based on Loading, the Bone Cement & Glue market is segmented into Antibiotic-loaded bone cement, and non-Antibiotic-loaded bone cement. The Antibiotic-loaded bone cement segment is is anticipated to have the highest shares considering the applications as Antibiotic-loaded bone cement is also commonly used in revision surgeries, where there is a higher risk of infection due to the presence of existing implants, in addition, the effectiveness of antibiotic-loaded bone cement in reducing infection rates has been supported by clinical evidence and guidelines, making it a widely accepted and evidence-based practice. Likewise, Antibiotic-loaded bone cement maintains biocompatibility and bonding strength comparable to plain bone cement, making it a safe and effective option for surgical use.

US accounted for the largest share of the North American Bone cement & glue industry in 2022.

Based on the region, the North American bone cement & glue market is segmented into US and Canada. In 2022, the US accounted for the largest share of the North American Bone cement & glue market. Growth in this market can be attributed to presence of stringent regulatory standard, rising healthcare expenditure, the increasing number of orthopedic surgical procedures performed in the US, the rising geriatric population, and the strong presence of bone cement & glue manufacturers.

Direct Purchase of the Global Bone Cement & Glue Market Research Report at https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=131540876&utm_source=Ganesh&utm_medium=P

India registered the highest growth rate in Asia Pacific Bone cement & glue industry.

The APAC bone cement & glue market is segmented into Japan, China, India, and Rest of Apac. In 2022, India accounted for the highest growth rate of the Asian bone cement & glue market. The high growth rate of India can be attributed to the rising of a medical tourism in orthopedic surgery sector and the increasing geriatric population. An increase in the number of elderly people gives rise to various orthopedic and diseases which is highly susceptible to several procedures. Therefore, growth in this population segment will directly drive the demand for bone cement & glue products.

The Germany in European Bone cement & glue industry to witness the second highest growth rate during the forecast period.

The Europe bone cement & glue market is segmented into Germany, France, the UK, and the Rest of Europe. Germany is registered the highest growth rate during the forecast period. The major factors contributing to the growth of this market are the high prevalence ofold age population, rising in sport related injuries, orthopedic cases, increasing R&D activities, strategic developments by key players.

In 2022, Stryker (US), held the leading position in the market. The company’s large share can be attributed to its broad range of Bone cement and strong global presence. Zimmer Biomet (US), held the second position in the Bone cement & glue market in 2022.